You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker
- 2. Assessment of prostate cancer aggressiveness through the combined analysis of prostate MRI and 2.5D deep learning models
- 3. Prognostic value of lymph node ratio in patients with non-small cell lung cancer: a systematic review and meta-analysis
- 4. Aspirin a day keeps bowel cancer at bay
- 5. Scientists uncover immune cells that help prostate cancer resist treatment — and reveal a way to stop them
- 6. Top biotech deals in June 2025
- 7. Expression of Insulin-like growth factor 2 mRNA-binding protein 3 and its diagnostic value in breast cancer
- 8. Breast cancer survivors may have lower risk of developing Alzheimer's disease, study finds
- 9. The fatal mutation that lets cancer outsmart the human immune system
- 10. Health Check: Promedicus shares smash record $300 barrier on back of mega deals
Last updated at 16:48 GMT
Hot News Makers
Health/Pharma Companies
-
60523.83
-
57773.86
-
41084.57
-
8762.40
-
8556.60
-
7254.51
-
6257.02
-
5452.48
-
4149.37
-
4138.32
Drugs, Treatments, Trials
-
158588.78
-
24145.16
-
13294.72
-
9489.34
-
9024.73
-
5149.05
-
4689.84
-
3904.29
-
3759.32
-
3559.72
Last updated at 16:10 GMT
